Skip to content

Pasadena Star News

49°F
Tuesday, April 14th 2026

e-Edition

Trending:

Recent Quotes
My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

53.73 +3.35 (+6.65%)
Streaming Delayed Price Updated: 10:33 AM EDT, Apr 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Twist Bioscience Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Biotech Beat Nvidia in 2025. Can It Do It Again? ↗
Big pharma and biotech take the earnings stage with reports from Eli Lilly and Novo Nordisk leading the lineup. Will they help the industry once again outperform AI champ Nvidia? 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Cold Chain, High Stakes: A Deep Dive into Azenta’s (AZTA) Life Sciences Transformation
Date: February 5, 2026 Introduction In the high-stakes world of life sciences, the "cold chain" is the invisible backbone of modern medicine. From the development of mRNA vaccines to the emerging... 
Via Finterra
Topics Artificial Intelligence Earnings Economy
News headline image
TWST Shares Rise 8% — What’s Driving The Rally? ↗
Twist Bioscience Corporation hiked its fiscal year 2026 revenue guidance on the heels of a first quarter earnings report that beat Wall Street estimates. 
Via Stocktwits
Topics Artificial Intelligence
TWIST BIOSCIENCE CORP (NASDAQ:TWST) Reports Mixed Q1 FY2026 Results with Revenue Beat and Wider Loss ↗
Via Chartmill
News headline image
Earnings Scheduled For August 4, 2025 ↗
 
Via Benzinga
News headline image
Preview: Twist Bioscience's Earnings ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 5, 2025 ↗
 
Via Benzinga
News headline image
What's Next: Twist Bioscience's Earnings Preview ↗
 
Via Benzinga
News headline image
Twist Bioscience Q1 2026 Earnings Call Transcript ↗
Twist Bioscience Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Twist Bioscience Eyes Profit Turnaround In 2026 After Narrowing Losses ↗
Twist Bioscience reports mixed Q4 earnings with a loss of 45 cents, sales of $99.01 million beating consensus. 
Via Benzinga
News headline image
Twist Bioscience Corp (NASDAQ:TWST) Stock Falls After Q4 Earnings Miss ↗
Twist Bioscience Q4 2025 earnings miss analyst estimates on revenue and EPS, triggering a sharp pre-market stock decline. 
Via Chartmill
Topics Earnings
News headline image
Top Wall Street Forecasters Revamp Twist Bioscience Expectations Ahead Of Q4 Earnings ↗
 
Via Benzinga
News headline image
Earnings Outlook For Twist Bioscience ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 14, 2025 ↗
 
Via Benzinga
News headline image
This Twist Bioscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗
 
Via Benzinga
News headline image
WW International, Replimune Group, Datavault AI, GRAIL And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
Topics Artificial Intelligence
News headline image
Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns ↗
Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall Street is overlooking its potential. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Cathie Wood's Ark Dumps Block Stock Worth $4.8 Million As Bitcoin-Heavy Company Preps Q2 Results ↗
Cathie Wood-led Ark Invest executed a significant trade in Block Inc. (NYSE:XYZ) on Tuesday. 
Via Benzinga
News headline image
Twist Bioscience Turns The Tide: Q3 Sales Jump, Beats Earnings ↗
Twist Bioscience beat Q3 revenue estimates, improved gross margins, and narrowed its full-year outlook while forecasting EBITDA breakeven fiscal 2026. 
Via Benzinga
News headline image
Twist Bioscience (TWST) Q3 Profit Surges ↗
Via The Motley Fool
News headline image
Twist Bioscience Corp (NASDAQ:TWST) Reports Mixed Q3 2025 Results with Revenue Miss and EPS Beat ↗
Twist Bioscience reported mixed Q3 2025 results, missing revenue estimates at $96.06M but beating EPS at -$0.47. Shares fell 5% pre-market as investors focused on the sales shortfall. 
Via Chartmill
News headline image
Cathie Wood's Ark Invest Continues To Offload Coinbase, Bets Big On SoFi Technologies ↗
Cathie Wood-led Ark Invest made notable trades on Friday, including selling shares in Coinbase and Roblox. 
Via Benzinga
News headline image
Cathie Wood Reiterates 'Profound' AI Application In Healthcare As Researchers Discover 'Cancer Survival Outcomes' By Facial Photograph Analysis: Here Are The Stocks That Could Benefit ↗
Cathie Wood underscored the application of AI in the healthcare sector by sharing new research by Mass General Brigham. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Cathie Wood Says AI Innovation In Healthcare Will Be More 'Profound' Than Autonomous Taxi Networks, Humanoid Robots ↗
Cathie Wood highlights the rising applications of AI and how it is poised to impact the health care space. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Where Twist Bioscience Stands With Analysts ↗
 
Via Benzinga
News headline image
Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday ↗
Ark Invest made notable trades on Feb. 28, 2025. They purchased shares in ACHR, RXRX, TEM, and IRDM, while selling shares in TWST, ADYEY, ACCD, and EXAS. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Cathie Wood's Ark Invest Loads Up On Iridium, Twist Bioscience, Offloads Roku: Here Are Key Ark Trades This Friday ↗
Cathie Wood-led Ark Invest made trades involving IRDM, TWST, PD, BEAM, ROKU, and IBTA. 
Via Benzinga
News headline image
Cathie Wood Dumps $16 Million Worth Of Palantir Stock After Record Highs ↗
On Monday, February 10, 2025, the Cathie Wood-led Ark Invest sold nearly $16 million worth of Palantir shares amid a spike in the share price of the company. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.